DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Sastre J, Aranda E, Massutí B. et al.
Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: comparative outcomes from the 03-TTD-01 phase III study.
Crit Rev Oncol Hematol 2009;
70: 134-139
We do not assume any responsibility for the contents of the web pages of other providers.